Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic Variants in the Transcription Factor Network: The Impact of <i>FOXC1, NOTCH1, RORC, FOXC</i>2 and <i>SOX18</i> in Primary Lymphedema.

Lymphology·2025
Same author

Genetic Variants in <i>LZTR1, MAP2K1</i> and <i>RAF1</i>: Insights into the Role of RAS-MAPK Pathway in Primary Lymphedema.

Lymphology·2025
Same author

Genetic Study of HGF-MET Signaling Pathway in Primary Lymphedema Patients: Supporting Evidence for Loss of Function Variants in HGF.

Lymphology·2025
Same author

Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR-positive/HER2-negative BC patients: results from the multicenter PALMARES-2 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Corrigendum to "Navigating the complex relationship between human gut microbiota and breast cancer: Physiopathological, prognostic and therapeutic implications" [Cancer Treat. Rev. 130 (2024) 102816].

Cancer treatment reviews·2024
Same author

Genetic Variants in Genes Correlated to the PI3K/AKT Pathway: The Role of <i>ARAP3, CDH5, KIF11</i> and <i>RELN</i> in Primary Lymphedema.

Lymphology·2024

Related Experiment Video

Updated: Jul 10, 2025

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

1.7K

Omics sciences and precision medicine in thyroid cancer.

K Dhuli1, M C Medori1, K Donato2

  • 1MAGI'S LAB, Rovereto (TN), Italy.

La Clinica Terapeutica
|November 23, 2023
PubMed
Summary

Omics sciences like genomics and proteomics help identify molecular markers for personalized thyroid cancer treatment. Targeted therapies, guided by these markers, show promise in improving patient outcomes, especially for advanced cases.

Keywords:
biomarkerdiagnosisgenomicsmetabolomicsprecision medicinethyroid cancertreatment

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
00:07

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.3K
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

555

Related Experiment Videos

Last Updated: Jul 10, 2025

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

1.7K
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
00:07

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.3K
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

555

Area of Science:

  • Endocrinology
  • Oncology
  • Molecular Biology

Background:

  • Thyroid cancer is a prevalent endocrine malignancy with persistent recurrence and mortality.
  • Personalized treatment strategies are crucial due to the disease's heterogeneity.
  • Omics sciences offer high-throughput methods to explore thyroid cancer's molecular landscape.

Purpose of the Study:

  • To review the application of omics sciences in understanding thyroid cancer.
  • To highlight the role of molecular markers in diagnosis, prognosis, and treatment selection.
  • To discuss the integration of omics data for precision medicine in thyroid cancer.

Main Methods:

  • Systematic review of pertinent scientific literature.
  • Focused research strategy for selecting emblematic articles.
  • Synthesis of existing sources for a thorough and precise overview.

Main Results:

  • Genomics identified key alterations (e.g., BRAF, RAS mutations).
  • Transcriptomics revealed genes involved in proliferation, invasion, and metastasis.
  • Proteomics and metabolomics uncovered biomarkers and altered pathways for early detection and therapeutic targets.

Conclusions:

  • Omics sciences provide molecular insights for personalized thyroid cancer therapy.
  • Targeted therapies based on molecular markers improve patient prognosis.
  • Precision medicine integrating omics data offers advanced treatment options, exemplified by BRAF-mutated thyroid cancer response to targeted drugs.